支架回收器管道 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者（2024 年版）

該報告提供了有關支架取回器管道的全面信息，包括處於不同開發階段的產品的比較分析以及正在進行的臨床試驗的數據。

目錄

第1章 目錄

第2章簡介

第3章 開發中產品

• 支架回收器 - 管道產品：依開發階段劃分
• 支架回收器 - 管道產品：按地區
• 支架回收器 - 管道產品：依監管途徑
• 支架回收器 - 管道產品：依預計核准日期
• 支架回收器 - 正在進行的臨床試驗

第4章 支架回收器-各公司在研產品

• 支架回收器公司 - 管道產品：依開發階段
• 支架回收器 - 管道產品：依開發階段劃分

第5章 支架取回器企業及產品概述

• Amnis Therapeutics Ltd：公司概況
  • Amnis Therapeutics Ltd：管道產品和正在進行的臨床試驗概述
• Biomedical Solutions Inc：公司概況
  • Biomedical Solutions Inc：管道產品和正在進行的臨床試驗概述
• Capital Medical University：公司概況
  • Capital Medical University：在研產品及正在進行的臨床試驗概況
• HeMo Bioengineering Ltd：公司概況
  • HeMo Bioengineering Ltd：管道產品和正在進行的臨床試驗概述
• Insera Therapeutics LLC：公司概況
  • Insera Therapeutics LLC：管道產品和正在進行的臨床試驗概述
• Medtronic Plc：公司概況
  • Medtronic Plc：管道產品和正在進行的臨床試驗概述
• MicroPort NeuroScientific Corp：公司概況
  • MicroPort NeuroScientific Corp：在研產品和正在進行的臨床試驗概述
• MiVi Neuroscience Inc：公司概況
  • MiVi Neuroscience Inc：管道產品和正在進行的臨床試驗概述
• Nanjing Kanite Medical Technology Co Ltd：公司概況
  • Nanjing Kanite Medical Technology Co Ltd：：在研產品概況及正在進行的臨床試驗
• NeuroVasc Technologies Inc：公司概況
  • NeuroVasc Technologies Inc：管道產品和正在進行的臨床試驗概述
• OrbusNeich：公司概況
  • OrbusNeich：管道產品和正在進行的臨床試驗概述
• Perflow Medical 有限公司：公司概況
  • Perflow Medical, Ltd.：管道產品和正在進行的臨床試驗概述
• Shanghai MicroPort Medical Group Co Ltd：公司概況
  • Shanghai MicroPort Medical Group Co Ltd：在研產品及正在進行的臨床試驗概述
• SinoMedCare Biotech Co Ltd：公司概況
  • SinoMedCare Biotech Co Ltd：在研產品及正在進行的臨床試驗概述
• Sree Chitra Tirunal Institute for Medical Sciences & Technology：公司概況
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology：管道產品和正在進行的臨床試驗概述
• Triticum Medical Ltd.：公司概況
  • Triticum Medical Ltd.：管道產品和正在進行的臨床試驗概述
• Vesalio LLC：公司概況
  • Vesalio LLC：管道產品和正在進行的臨床試驗概述
• Zhejiang Kindly Medical Devices Co Ltd：公司概況
  • Zhejiang Kindly Medical Devices Co Ltd：在研產品及正在進行的臨床試驗概況
• Zylox-Tonbridge Medical Technology Co Ltd：公司概況
  • Zylox-Tonbridge Medical Technology Co Ltd：管道產品概述和正在進行的臨床試驗

第 6 章支架回收器 - 最新發展

• 2024 年 9 月 4 日：Rapid Medical 報告使用 TIGERTRIEVER13 對 DISTALS 試驗進行中期安全分析，並未發現中型血管阻塞的安全性問題
• 2024 年 8 月 26 日：Zylox-Tonbridge 公佈 2024 年中期業績表現強勁，實現顯著增長和盈利
• 2024 年 7 月 10 日：繼 Neva Net 5.5 MM 在國際上取得成功後，Vesalio 推出 Neva Net 4.0 MM
• 2024 年 5 月 14 日：Rapid Medical 使用世界上第一台機器人血栓清除設備成功進行了缺血性中風手術
• 2024 年 2 月 5 日：Wallabyphenox 透過 Prost 試驗大膽樹立了實證醫學的新基準
• 2023 年 12 月 14 日：Rapid Medical 的血管重建裝置在日本獲得批准
• 2023 年 11 月 16 日：Rapid Medical 的 TIGERTRIEVER 為患有 ICAD 的缺血性中風患者帶來了首次成功
• 2023 年 11 月 5 日：phenox 的預設 LITE 血栓切除裝置獲得額外 510(K) 批准

第7章附錄

GlobalData's Medical Devices sector report, "Stent Retrievers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Stent Retrievers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Stent Retrievers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Stent Retrievers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Stent Retrievers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Stent Retrievers Overview

3 Products under Development

• 3.1 Stent Retrievers - Pipeline Products by Stage of Development
• 3.2 Stent Retrievers - Pipeline Products by Territory
• 3.3 Stent Retrievers - Pipeline Products by Regulatory Path
• 3.4 Stent Retrievers - Pipeline Products by Estimated Approval Date
• 3.5 Stent Retrievers - Ongoing Clinical Trials

4 Stent Retrievers - Pipeline Products under Development by Companies

• 4.1 Stent Retrievers Companies - Pipeline Products by Stage of Development
• 4.2 Stent Retrievers - Pipeline Products by Stage of Development

5 Stent Retrievers Companies and Product Overview

• 5.1 Amnis Therapeutics Ltd Company Overview
  • 5.1.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Biomedical Solutions Inc Company Overview
  • 5.2.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Capital Medical University Company Overview
  • 5.3.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 HeMo Bioengineering Ltd Company Overview
  • 5.4.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Insera Therapeutics LLC Company Overview
  • 5.5.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Medtronic Plc Company Overview
  • 5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 MicroPort NeuroScientific Corp Company Overview
  • 5.7.1 MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 MiVi Neuroscience Inc Company Overview
  • 5.8.1 MiVi Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Nanjing Kanite Medical Technology Co Ltd Company Overview
  • 5.9.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 NeuroVasc Technologies Inc Company Overview
  • 5.10.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 OrbusNeich Company Overview
  • 5.11.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Perflow Medical, Ltd. Company Overview
  • 5.12.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.13.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 SinoMedCare Biotech Co Ltd Company Overview
  • 5.14.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Triticum Medical Ltd. Company Overview
  • 5.16.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Vesalio LLC Company Overview
  • 5.17.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Zhejiang Kindly Medical Devices Co Ltd Company Overview
  • 5.18.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
  • 5.19.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Stent Retrievers- Recent Developments

• 6.1 Sep 04, 2024: Rapid Medical Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER13
• 6.2 Aug 26, 2024: Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
• 6.3 Jul 10, 2024: Vesalio Introduces Neva Net 4.0 MM Following International Success of Neva Net 5.5 MM
• 6.4 May 14, 2024: Rapid Medical Completes Successful Ischemic Stroke Procedures with the World's First Robotic Thrombectomy Device
• 6.5 Feb 05, 2024: Wallabyphenox Boldly Sets New Benchmark in Evidence-Based Medicine with the Prost Trial
• 6.6 Dec 14, 2023: Rapid Medical receives Japanese approval for revascularisation device
• 6.7 Nov 16, 2023: Rapid Medical's TIGERTRIEVER Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD
• 6.8 Nov 05, 2023: phenox Receives Additional 510(K) Clearance for pREset LITE Thrombectomy Device

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials
• Stent Retrievers Companies - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials